Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

Abstract
No abstract available
Funding Information
  • CDC Prevention Epicenters Program (U54CK000164, to DJS)
  • NIH/NIAID (K23AI095357, to DJA)
  • National Center for Advancing Translational Sciences, NIH (UL1TR001111)

This publication has 29 references indexed in Scilit: